Pro-Dex Research and Development Expenses 2010-2024 | PDEX

Pro-Dex research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$87.4B
Becton Dickinson (BDX)$57.1B
Cardinal Health (CAH)$32.5B
Straumann Holding AG (SAUHY)$18.7B
Labcorp (LH)$18.2B
Cooper (COO)$15.9B
West Pharmaceutical Services (WST)$14.6B
Align Technology (ALGN)$12.5B
Henry Schein (HSIC)$7.9B
Merit Medical Systems (MMSI)$5.4B
Patterson (PDCO)$2.8B
DENTSPLY SIRONA (XRAY)$2.6B
CONMED (CNMD)$1.5B
STAAR Surgical (STAA)$833M
Lifevantage (LFVN)$169M